ERBB2 and breast carcinoma: The three clinically most-useful receptors status to characterize breast cancer cells are the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) that can impact therapy and prognosis [2].